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Abstract
Background: The precise molecular changes that occur when a neural stem (NS) cell switches from a programme of self-
renewal to commit towards a specific lineage are not currently well understood. However it is clear that control of gene
expression plays an important role in this process. DNA methylation, a mark of transcriptionally silent chromatin, has
similarly been shown to play important roles in neural cell fate commitment in vivo. While DNA methylation is known to
play important roles in neural specification during embryonic development, no such role has been shown for any of the
methyl-CpG binding proteins (Mecps) in mice.
Methodology/Principal Findings: To explore the role of DNA methylation in neural cell fate decisions, we have investigated
the function of Mecps in mouse development and in neural stem cell derivation, maintenance, and differentiation. In order
to test whether the absence of phenotype in singly-mutant animals could be due to functional redundancy between Mecps,
we created mice and neural stem cells simultaneously lacking Mecp2, Mbd2 and Zbtb33. No evidence for functional
redundancy between these genes in embryonic development or in the derivation or maintenance of neural stem cells in
culture was detectable. However evidence for a defect in neuronal commitment of triple knockout NS cells was found.
Conclusions/Significance: Although DNA methylation is indispensable for mammalian embryonic development, we show
that simultaneous deficiency of three methyl-CpG binding proteins genes is compatible with apparently normal mouse
embryogenesis. Nevertheless, we provide genetic evidence for redundancy of function between methyl-CpG binding
proteins in postnatal mice.
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Introduction
DNA methylation is essential for mammalian development.
Mouse embryos lacking either the de novo DNA methyltransfer-
ases (Dnmt3a and Dnmt3b) or the maintenance DNA methyl-
transferase (Dnmt1) die shortly after gastrulation [1,2]. DNA
methylation in mammals is predominantly associated with gene
silencing, and DNA methylation-deficient cells and embryos show
inappropriate expression of wide variety of genes [2–6]. The
transcriptional silencing effect of DNA methylation is mediated at
least in part through the action of the methyl-CpG binding
proteins (Mecps). Mecps bind to methylated DNA and recruit
chromatin remodelling proteins to facilitate transcriptional
silencing (reviewed in [7]). Specific recognition of methylated
DNA is mediated either via a methyl-CpG binding domain (MBD)
or C2H2 zinc fingers. The MBD-containing Mecps include Mbd1,
Mbd2, Mbd4 and Mecp2 [8–10], while Kaiso and the recently
described ZBTB4 and ZBTB38 proteins use zinc fingers to bind
methylated DNA [11,12]. Both Kaiso and Mbd1 have the ability
to bind unmethylated DNA as well as methylated DNA [13,14],
while Mbd4 preferentially binds G-T mismatches at methylated
CpG sites [15]. Mecps have been shown to be associated with
various methylated genes in vivo, however Mecp-dependent gene
silencing has been shown for only a subset of these genes [16–21].
Targeted mutagenesis in mice has been used to study the
functions of Mecps in vivo. Despite being widely expressed in mice,
none of the Mecps assayed thus far is required for embryogenesis.
Mice lacking Mbd1 are viable and fertile, displaying no overt
phenotypes, although further investigation revealed that Mbd1
(2/2)
adult neural stem cells showed a defect in neuronal differentiation
[22]. Mice lacking Mbd2 are similarly viable and fertile, but show
abnormal maternal behaviour [23] and defects in T-cell develop-
ment [20]. Mice deficient for Zbtb33, the gene which encodes the
Kaiso protein, display no overt phenotypes [24]. In contrast,
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an average of six weeks of age [25,26], while mutations in the
human MECP2 gene cause a range of neurological disorders, the
most prevalent of which is Rett syndrome [27,28].
Of all the Mecps for which functional data exists, only Mbd1
has been shown to play a role in neuronal differentiation. However
it is notable that this function was shown for adult neural
progenitors, but embryonic neurogenesis occurred normally in the
absence of Mbd1 [22]. Mecp2 was specifically shown to function
in neuronal maturation, not differentiation [29,30], and while
Mbd2 is implicated in controlling some aspects of behaviour, it has
not been shown to play any role in neurons or neural development
[23]. Despite the finding that Zbtb33-null mice show no neuronal
phenotypes [24], the observation that Kaiso is highly expressed in
brain [31] and was reported to be a component of the N-CoR co-
repressor complex in HeLa cells [32] is suggestive of some neural
function for this protein.
Although methyl-CpG binding proteins are expressed at
varying levels in a wide variety of tissues and corresponding
cDNAs can be detected in embryonic libraries, there is currently
no evidence that mammalian methyl-CpG binding proteins play
any role in embryonic development. This is in stark contrast to the
situation in Xenopus leavis, where both xMecp2 and xKaiso are
essential for normal embryogenesis [33–35]. This apparent
discrepancy could be due to a significant difference between
amphibians and mammals in the function of Mecps: mammalian
Mecps might serve exclusively or predominantly redundant roles
in embryogenesis, while amphibian Mecps each have distinct
functions. Alternately mammalian Mecps may play no essential
role during embryogenesis, but function only postnatally. In an
attempt to distinguish between these two possibilities, we created
mice and neural stem cells simultaneously lacking the three well-
characterised methyl-CpG binding proteins not implicated in
neuronal differentiation, namely Mbd2, Mecp2 and Kaiso. While
we found no evidence for functional redundancy between these
proteins in embryonic development, we do find evidence for
overlapping functions in postnatal animals and in neural
specification of neural stem cells in culture. Our findings strongly
support the notion that in mammals, unlike in amphibians,
methyl-CpG binding proteins are dispensable for embryonic
development, but perform overlapping functions during neural
development.
Results
Mbd2, Mecp2 and Kaiso are not required for mouse
embryogenesis
To determine whether Mecps play a functionally redundant role
during embryonic development, mice harbouring mutations for
Mbd2 [23], Mecp2 [26] and Zbtb33 [24] were intercrossed to make
triple mutant animals. Mecp2 and Zbtb33 are both located on the X
chromosome, while Mbd2 is autosomal. In order to breed triple
knockout (3KO) mice, Mbd2
(2/2) or Mbd2
(+/2) females carrying
the Zbtb33 (Kaiso) and Mecp2 null alleles on the same X
chromosome (designated ‘‘X
KMX’’ in Table 1) were mated to
Mbd2-null males. All expected combinations of single, double and
triple mutant mice were viable and obtained at near-Mendellian
frequencies (Table 1). Consistent with previous reports, Mbd2 and
Zbtb33-single null animals displayed no obvious phenotypes
[23,24]. Mbd2/Zbtb33-double null animals also showed no overt
phenotypes. All mice carrying the Mecp2-null allele developed the
characteristic Rett-like symptoms described previously [25,26],
and the presence or absence of Mbd2 or Zbtb33genes did not alter
the nature of the observable symptoms displayed by these mice, as
previously reported [26]. Symptoms observed included tendency
to have overgrown teeth, tremors, feeding, breathing irregularities
and general mobility. No biometric tests were performed on these
animals, so it is formally possible that the triple mutation resulted
in some subtle changes in behaviour as compared to the single
Mecp2 mutation. In contrast, the average age of death for Mecp2-
null mice did vary depending upon the mutational status of the
other genes (Figure 1A). While Mecp2-null mice died at an average
of 58 days, Mecp2-null mice also lacking the Mbd2 gene or both the
Mbd2 and Zbtb33genes died significantly earlier, averaging 48 days
(p,0.05) or 44 days (p,0.005), respectively (Figure 1B). Mbd2
(2/2)
mothers are known to display a nurturing phenotype [23], but the
vast majority of double and triple null mice died after weaning and
no correlation was found between age of death and maternal
genotype at the Mbd2 locus (Figure 1A and data not shown). Thus
these genetic data are consistent with functional redundancy
existingbetween methyl-CpGbindingproteinsinpostnatalanimals.
Methyl-CpG binding proteins are expressed in neural cell
types
In order to determine whether Mecp activity is detectable in
neural cell types, expression levels of methyl-CpG binding protein
genes were measured quantitatively in embryonic stem (ES) cells
and their differentiated progeny (Sox1-expressing neuroepithelial
cells, neural stem cells and Gfap-expressing astrocytes; see
Materials and Methods for details). Sox2 expression was used as
a control, as its expression pattern is well characterised in neuronal
development [36,37]. As expected, Sox2 is well expressed in ES
cells, NS cells, and neurons (Figure 2A). All cells present in the
astrocyte-like cultures express the astrocyte marker Gfap (e.g. [38]
and see below), although after three days in differentiation
conditions they still show appreciable expression of NS cell
markers (e.g. Sox2 and Nestin; Figure 2A). Neural cultures contain a
heterogeneous mix of cells including NS cells, neurons and
astrocytes [38]. Expression of all four methyl-CpG binding protein
genes was detectable in each of the cell types used in this study.
Mecp2 expression was highest in neuronal cultures, consistent with
its published roles in neuronal maturation, but not differentiation
[29,30]. Mbd1, the only Mecp for which a function in NS cells has
been reported [22], was well expressed in NS cells and neurons.
Table 1. Generation of triple KO mice.
Genotypes
a
(+/2)(X
KMX)
6(2/2)(XY)
b
(2/2)(X
KMX)
6(2/2)(XY)
b
Mbd2(+/2)Zbtb33(+/y)Mecp2(+/y) 27
Mbd2(2/2)Zbtb33(+/y)Mecp2(+/y) 21 7
Mbd2(+/2)Zbtb33(2/y)Mecp2(2/y) 23
Mbd2(2/2)Zbtb33(2/y)Mecp2(2/y) 18 5
Mbd2(+/2)Zbtb33(2/y)Mecp2(+/y)
c 4
Mbd2(2/2)Zbtb33(2/y)Mecp2(+/y)
c 61
Mbd2(+/2)Zbtb33(+/y)Mecp2(2/y)
c 2
Mbd2(2/2)Zbtb33(+/y)Mecp2(2/y)
c 52
aGenotypes of male mice at weaning or death.
bGenotypes of parents crossed to produce listed progeny. ‘‘(+/2)’’ and ‘‘(2/2)’’
refer to the Mbd2 genotype, while ‘‘X
KM’’ indicates an X chromosome
harbouring null alleles at both Zbtb33 (Kaiso)a n dMecp2.
cGenotypes arising from nondisjunction between the Zbtb33 and Mecp2 loci
during maternal meiosis.
doi:10.1371/journal.pone.0004315.t001
Redundancy amongst Mecps
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was expressed only moderately in neuronal cultures, it showed
highest expression in astrocyte-like cultures. Nevertheless expres-
sion of all methyl-CpG binding protein genes was detectable in NS
cells (Figure 2A, B).
Mbd2, Mecp2 and Kaiso are dispensable for neurosphere
formation and potency
DNA methylation has been shown to restrict astroglial
differentiation in the developing mouse brain [39]. If this function
of DNA methylation is mediated by Mecps, we would expect to
see precocious or preferential astroglial differentiation of Mecp-
deficient neurospheres. In order to test this possibility, neuro-
spheres were made from both wild-type embryos and from 3KO
embryos at embryonic day 14.5. We saw no obvious difference in
the formation, frequency or size of neurospheres made from wild-
type and 3KO embryos (data not shown). Neurospheres were
cultivated for one week and then plated out in adherent culture in
differentiation medium to assess their differentiation potential. In
order to test the ability of neurospheres to self-renew, primary
neurospheres were dissociated to single cells and allowed to form
secondary neurospheres prior to plating out in differentiation
conditions. We found that primary and secondary neurospheres
derived from 3KO embryos showed a similar degree of formation,
frequency, size (data not shown) and potential to form neurons and
Figure 1. Genetic interaction between Mecps in postnatal animals. A. Cumulative plot of percentage of Mecp2-null mice (solid black line),
Mecp2/Kaiso-double null mice (dotted black line), Mecp2/Mbd2-double null mice (dotted grey line) and Mecp2/Mbd2/Kaiso-triple null mice (solid
grey line) surviving over time. All mice used in this analysis were produced from mouse lines that had undergone at least 6 generations of
backcrossing to C57Bl/6 mice. B. Statistical analysis of the data pictured in A. N refers to the number of mice in the sample. A two-tailed Mann-
Whitney test (http://faculty.vassar.edu/lowry/utest.html) was used to calculate p-values. pMecp2 gives the p-value as compared to the Mecp2 single-
null data, and p3KO gives the p-value as compared to the triple null data.
doi:10.1371/journal.pone.0004315.g001
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result indicates that Mbd2, Mecp2 and Kaiso are not important
for the DNA methylation-mediated inhibition of astroglial
differentiation in neurospheres.
Derivation and differentiation of 3KO neural stem cell
lines
Neurospheres have long been used to study neural stem cells,
however they have the limitation of being composed of a
heterogeneous mix of neural stem cells and differentiating progeny
[40]. Therefore it was possible that any subtle effect of Mecp-
deficiency on neural differentiation might not be detectable using
this system. In contrast, neural stem (NS) cell lines [38] are a
completely homogeneous stem cell population, which were
subsequently used to more rigorously address whether Mecps
play any role in neural differentiation. NS cell lines were made
from both wild-type and 3KO 14.5dpc embryos. We could see no
genotype-dependent differences in the efficiency or rate of
establishment of NS cell lines. Similarly, no difference in
proliferation rates could be detected between the 3KO and wild-
type NS cells (Fig. 4A). Like wild-type NS cells, 3KO NS cells were
able to form colonies from single cells after plating at clonal density
(data not shown). Both wild-type and 3KO NS cell lines showed
uniform expression of neural stem cell markers (RC2, nestin and
vimentin) and an absence of differentiated cell markers (TuJ1 and
Gfap) by immunofluorescence (Fig. 4B). To test whether the loss of
three methyl-CpG binding proteins was compensated for by
upregulation of other methyl-CpG binding proteins, expression of
Mbd1, Mbd2, Mbd3, Mbd4, Mecp2, Zbtb4, Zbtb33 and Zbtb38 was
monitored in three independently-derived 3KO NS lines, in all
three of the single mutant NS lines and in three different wild-type
NS lines (Figure 4C). This analysis showed no evidence for
consistent up-regulation of any of the known methyl-CpG binding
protein genes in 3KO NS cells. Therefore we conclude that Mbd2,
Mecp2 and Kaiso are dispensable for NS cell derivation and
maintenance.
Figure 2. Methyl-CpG binding proteins in NS cells. Expression of Mbd1, Mbd2, Mecp2, Zbtb33 and Sox2 detected by RT-PCR in ES cells (blue
boxes), FACS-purified, Sox1-expressing ES-derived neural progenitors (green boxes), NS cells (red boxes), NS cell -derived neuronal cultures (black
boxes), NS cell -derived astrocyte cultures (white boxes), and whole brain (grey boxes). Error bars indicate SEM. For each cell sample, expression was
normalized to Gapdh expression, and is shown relative to that seen in adult mouse brain. B. Detection of Mecp2 protein in NS cells. Mecp2 can be
detected by antibody staining (red) in NS cell cultures, also expressing the NS cell marker RC2 (green). The Dapi-stained image is shown at right.
doi:10.1371/journal.pone.0004315.g002
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response to serum stimulation and produce cells displaying an
astrocyte-like morphology, indistinguishable from wild-type cells
(Figure 4D). We found no evidence for unscheduled or impaired
astroglial differentiation of 3KO NS cell cultures (Figure 4D and
data not shown). Nevertheless it remained possible that 3KO NS
cells would show early and/or preferential activation of Gfap upon
induction in culture. In order to test this possibility, activation of
Gfap expression was monitored 8, 12, 20 and 24 hours after
induction by serum stimulation in wild-type and 3KO NS cells. No
genotype-dependent difference in the activation rate of Gfap was
found between the different cell lines (data not shown). Neither
could we identify any genotype-specific differentiation differences
when varying passage number, cell density, serum concentration
or presence/absence of LIF (data not shown). Similarly, when
subjected to a neuronal differentiation protocol for two weeks
3KO NS cells were found to be capable of forming cells expressing
neuronal or glial markers that displayed either neuronal or
astrocytic morphologies, respectively (Figure 5A,B). Thus we
conclude that Mbd2, Mecp2 and Kaiso are not required for
formation of neurons or astrocytes from NS cells in culture.
No evidence for altered neurogenesis or gliogenesis in 3KO NS
cell cultures was detected after two weeks of differentiation.
However we did find evidence for Mecp function in initial
neuronal specification. Our standard neuronal differentiation
procedure involves the induction of neurogenesis through
Figure 3. Neurosphere potency. Wild-type (A) or 3KO (B) neurospheres made from E14.5 cortex were differentiated for five days and stained for ß-
tubulin III (red) and Gfap (green). C. Proportion of colonies formed staining for both neural (ß-tubulin III) and astrocyte (Gfap) markers when primary
or secondary neurosphere cultures were allowed to differentiate. Data for wild-type neurospheres are shown in open boxes; that for 3KO
neurospheres is shown in filled boxes. Error bars represent SEM.
doi:10.1371/journal.pone.0004315.g003
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PLoS ONE | www.plosone.org 5 January 2009 | Volume 4 | Issue 1 | e4315Figure 4. 3KO Neural stem cells. A. Proliferation rates of three 3KO NS cell lines (grey lines) and two wild-type NS cell lines (black lines) were
measured by the MTT assay over three days. Error bars represent SEM. B. Immunocytochemistry of the indicated NS cell markers (red staining) in one
wild-type NS cell line (top panels) and three independent 3KO NS cell lines. Cells were counterstained with Dapi (blue). C. Expression levels of the
genes indicated across the X-axis were measured in wild type, single mutant, and triple mutant NS cell lines (as indicated in the legend). Expression
was monitored in triplicate in two biological replicates by quantitative PCR, and results of a representative experiment is shown. Expression levels
were normalized to Sox2 expression and are shown relative to the levels found in an E14.5 cortex-derived wildtype NS cell line. The Zbtb33
2/y NS line
was made by Cre transfection of the Zbtb33
Flox/y NS line, as described [24], while the remaining mutant NS lines were all derived from E14.5dpc
embryos. D. Immunostaining of NS cell cultures after four days in the presence of serum and removal of growth factors to induce Gfap activation. Left
panels: bright field, right panels: Gfap (green), Dapi (blue). Top panels: WT cells, middle and bottom panels: two independent 3KO cell lines.
doi:10.1371/journal.pone.0004315.g004
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PLoS ONE | www.plosone.org 6 January 2009 | Volume 4 | Issue 1 | e4315Figure 5. Neural differentiation of 3KO NS Cells. NS cells were cultured for 15 days in neuronal differentiation conditions and immunostained
for ß-tubulin III (green) and Gfap (red) in panels 1 and 2, Map2 in panels 3 and 4, and for Gad67 (green), a marker of Gabaergic neurons, in panels 5
and 6. Cells were counterstained in Dapi (blue). Panels 1, 3, and 5: wild-type NS cells; panels 2, 4, and 6: 3KO NS cells. B. Quantitation of the number of
ß-tubulinIII expressing (white bars) and Gfap-expressing (grey bars) cells in 14 day neural differentiation cultures from wild-type (left) and 3KO (right)
NS cell cultures. Error bars represent SEM from three independent experiments. C. Quantitation of the number of ß-tubulinIII positive cells present in
NS cell cultures after seven days’ neuronal differentiation. Data is shown for three different wild-type and three different 3KO NS cell lines. Error bars
represent SEM from at least three independent experiments. The difference seen between the wild-type and 3KO lines is highly statistically significant
(p,0.0024, Bonferroni). D. Images of 7 day neural cultures from wild-type (left) or 3KO (right) NS cells, stained for ß-tubulin III (green) and Dapi (blue).
E. Relative percentage of ß-tubulin III positive cells present in NS cell cultures of indicated genotype after eight days’ neuronal differentiation. Error
bars represent SEM from at least four independent fields of cells. All cell lines were derived from E14.5 cortex except those labeled ‘‘Zbtb33 Flox’’ and
‘‘Zbtb33 KO’’, which are ES cell-derived NS lines, with the Zbtb33 KO line having been derived from the Zbtb33 Flox line by Cre-transfection and gene
deletion. Hence data for the Zbtb33 Flox line is included as an appropriate wild-type control for the Zbtb33 -null NS line.
doi:10.1371/journal.pone.0004315.g005
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growth stimulated by FGF withdrawal and addition of B27 to the
media for a further seven days [38]. When differentiation cultures
were stained after Egf withdrawal, but prior to removal of FGF, we
found that 3KO NS cultures showed significantly reduced number
of Tuj1-positive cells displaying an immature neural morphology
as compared to the wild-type cultures (Figure 5C). After a further
day of differentiation the difference is reduced although still
detectable (Figure 5E), but by 14 days of differentiation the 3KO
NS cultures appear to have completely recovered from this initial
defect as we could no longer detect a difference in the number of
Tuj1-expressing cells (Figure 5B). Hence we conclude that while
triple knockout NS cells show an initial impairment in neural
differentiation, this is a transient effect and the cells manage to
recover after a further week in culture.
To determine whether this observed defect in neural differen-
tiation is due to any one of these Mecp genes, or is indicative of
functional redundancy between them, we made NS cells lacking
each gene individually, i.e. Mecp2
2/y NS cells, Mbd2
2/2 NS cells,
and Zbtb33
2/y NS cells. Each line was subjected to the neural
differentiation protocol and Tuj1-expressing cells were counted
after 7 days. Each of the single mutant NS cell lines was found to
produce a normal number of neurons in this assay (Figure 5E).
Thus we conclude that the defect observed in triple knockout NS
cells likely results from some redundant function between these
three proteins.
Discussion
In this study we show that we can find no evidence for
functional redundancy between three methyl-CpG binding
proteins, Mecp2, Mbd2 and Kaiso, in embryonic development
or in the derivation or maintenance of neural stem cells in culture.
Nevertheless, we do provide evidence for a role for these three
proteins in differentiation of neural stem cells and in postnatal
mice. Mice lacking three methyl-CpG binding proteins succumb
to Mecp2-dependent effects significantly earlier than do Mecp2
single null mice, while Mbd2 and Zbtb33 single or double-null mice
show no reduced viability. Further we find an initial defect in
neuronal specification of triple null NS cells after one week of
differentiation. This manifests as delayed neuronal commitment,
but not as altered fate choice as the these cells are able to
overcome this initial defect and recover normal numbers of
neuron-like cells after a further week in culture. While other
studies have demonstrated a lack of redundant function for two or
more Mecps in silencing of specific loci (e.g. [41]), this study
provides the first evidence for a redundant function of Mecps in
mammalian cells.
Interestingly, it has recently been reported that expression of a
dominant negative Ntrk2 protein in embryonic cortical precursors
results in an initial decrease in the rate of neurogenesis, but that
cultures recover in the longer term to give normal differentiation
rates [42], mirroring very closely the phenotype we report here.
Mecp2 has previously been shown to maintain silencing of Bdnf,
the gene encoding an Ntrk2 ligand [17,43]. Tantalising as this
potential link is, we did not see a consistent difference in the
expression levels of Ntrk2 in our triple knockout NS cell lines
(Figure 4C).
We find no evidence for Mecp function during murine
embryogenesis (Table 1). Given that DNA methylation plays a
well documented role in neural cell fate specification [39,44,45]
and is essential for mammalian embryogenesis [2,5], our findings
support the conclusion that interpretation of the DNA methylation
mark by methyl-CpG binding proteins plays little if any role in
these functions. It is formally possible that any essential,
developmental functions of mammalian methyl-CpG binding
proteins are being carried out by one or both of the Kaiso-like
proteins Zbtb4 and Zbtb38 [12], and/or Mbd1. While we cannot
rule this possibility out, as yet no developmental functions have
been defined for Mbd1 [22], Zbtb4 or Zbtb38. Further, we did not
see increased transcript levels of Mbd1, Mbd4, Zbtb4 or Zbtb38 in
the multiple knockout NS cells (Figure 4C), making it unlikely that
increased expression of one or more of these is compensating for
loss of Mbd2, Mecp2 and Kaiso.
Despite a lack of evidence for a requirement for Mecps during
embryogenesis, we found evidence for overlapping functions in
postnatal animals (Figure 1). It is not clear why the 3KO mice
succumb to Mecp2-dependent death earlier than do Mecp2 single-
null mice. Given the similarity of symptoms displayed by all
Mecp2-null animals in this study prior to death, irrespective of
whether they also lack Mbd2 and/or Zbtb33, it is likely that Mbd2,
and possibly Kaiso, are able to compensate somewhat for the role
Mecp2 normally plays in the postmitotic neurons of Mecp2-null
mice, although phenotypic synergy between the different muta-
tions cannot be completely ruled out. The difference in life span
between Mecp2-single null and Mbd2/Mecp2-double null animals
was not seen in a previous report [26] in which mice were on a
mixed genetic background, whereas the mice in the current study
were on a C57Bl/6 background, indicating the existence of strain-
specific modifiers of life span in Mecp2-null mice. Using chromatin
immunoprecipitation, Klose et al. found no evidence for co-
localisation of MBD2 and MECP2 binding sites in a human lung
cell line [46], consistent with the observation of tissue-specific
functions for methyl-CpG binding proteins [22,24–26,47], and/or
for cooperative regulation by different Mecps biding to distinct
sites within a given gene.
Our finding that Mbd2, Mecp2 and Kaiso have no develop-
mental role in mammals contrasts with the situation in Xenopus
laevis, where depletion of xKaiso results in severe embryologic
defects [33,34] and xMecp2 is essential for normal neural
development [35]. This discrepancy may indicate the existence
of a significant difference in the use of DNA methylation and/or
methyl-CpG binding proteins in amphibians and mammals. The
Mbd3 protein provides evidence for a change in the use of methyl-
CpG binding proteins during mammalian evolution [48]. The
Mbd3 gene found in eutherian genomes encodes a protein
incapable of binding to methylated DNA due to point mutations
within its MBD [49], while non-eutherian vertebrate genomes
encode Mbd3 proteins containing an intact methyl-CpG binding
domain [48]. In contrast to the Mecps which are not important for
mammalian embryonic development, Mbd3 is essential for
embryogenesis in both mice and frogs [23,50].
Animal genomes underwent a significant change in DNA
methylation patterns at the invertebrate-vertebrate boundary,
which likely coincided with a change in the use of DNA
methylation by those genomes [51–53]. Amplification and
diversification of the Mecp family in vertebrates coincided with
the spreading of DNA methylation across the genome, and likely
contributes to a ‘fine tuning’ mechanism of gene expression
[53,54]. Given this evolutionary history, and the fact that no
evidence exists for an essential, embryonic function for any
mammalian methyl-CpG binding protein, we propose that the
mammalian Mecps have evolved to function predominantly or
exclusively to fine tune gene expression in postmitotic tissues. A
formal proof of this theory, requiring the simultaneous deletion (or
knock-down) of all known methyl-CpG binding transcriptional
repressor proteins in mammalian embryogenesis, has yet to be
achieved.
Redundancy amongst Mecps
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Animals
Mbd2-null [23], Mecp2-null [26] and Zbtb33-null [24] mice have
been described. Animal work was approved by the appropriate ethics
committees of the School of Biological Sciences, University of
Edinburgh, and by the UK Home Office. Multply mutant mice were
created by standard intercrossing. Zbtb33 and Mecp2 are located
approximately 36 Mb apart on the X chromosome (http://genome.
ucsc.edu/cgi-bin/hgGateway). To make mice doubly heterozygous
or doubly hemizygous for these two alleles, females harbouring the
Zbtb33 deletion on one X chromosomeand the Mecp2 deletion on the
other were crossed to wild type males, and any progeny inheriting
both mutant alleles were judged to have received a recombined X
chromosome containing both mutant alleles. Of 133 pups generated
from such crosses, 11 were judged to contain the recombined
chromosome, providing a recombination frequency of 8.3%.
Neurospheres and Neural stem cell culture
Neurospheres were prepared as described [55]. Embryonic age
E14.5 cortices were dissected and meninges removed. Cells were
mechanically dissociated, passed through a 40 mm nylon mesh
(BD Falcon) and suspended at a density of 5000/cm
2 in 25 cm
2
culture flasks in the presence of FGF (Prepotech) in DMEM/F12
supplemented with B27 and penicillin/streptomycin. After 7 days
primary neurospheres were subjected to form secondary neuro-
spheres by mechanical dissociation and prepared as explained
above. For differentiation, primary and secondary neurospheres
were plated on to poly-L-lysine-coated (Sigma) coverslips in the
presence of Neurobasal media supplemented with B27, L-
glutamine, 2-mercaptoethanol and penicillin/streptomycin for
5 days. Neural stem cell lines were made and maintained as
described [38]. Briefly, embryonic age E14.5 cortices were
dissected and dissociated as for neurospheres. The entire cell
suspension from each embryonic cortex was plated on 25 cm
2
flasks in NS media [38]. Cultures were allowed to form
neurospheres for 7 days, after which they were collected by
centrifugation and plated in gelatinised flasks. From this point cells
were maintained as an adherent monolayer and passaged when
30–50% confluent. Passage number was always kept as low as
possible to minimise the chances of genetic or epigenetic change in
the cultures and will typically be less than p30. Astrocytic and
neuronal differentiation was performed as described [37].
To generate Sox1-expressing neural precursors, Sox1-GFP
knock-in ES cells were cultured in DMEM/F12 media (Invitrogen)
supplemented with N2 and B27 (Invitrogen) as described [56].
Cultures were subjected to FACS purification of GFP-expressing
cells at day 6 of differentiation, followed immediately by RNA
extraction. ES with no GFP knock-in were similarly subjected to
this monolayer differentiation procedure and used as a control to
identify autofluorescence events.
RT-PCR
Expression levels of methyl-CpG binding protein genes were
measured quantitatively in embryonic stem (ES) cells, ES cell-
derived, FACS sorted, Sox1-Gfp positive cells [56], ES cell-derived
and E14.5 cortex-derived neural stem (NS) cell cultures [38],
Gfap-expressing astrocyte-like cultures (day 3) and neuronal
differentiation cultures (day 14) [38]. Sox2 expression was used
as a control, as its expression pattern is well characterised in
neuronal development [36,37]. All cells present in the astrocyte-
like cultures express the astrocyte marker Gfap (e.g. Figure 4C),
although after three days in differentiation conditions they still
show appreciable expression of NS cell markers. Neural cultures
contain a heterogeneous mix of neurons, astrocytes and NS cells as
described [38] (e.g. Figure 5A). Primer sequences are in Table 2.
Immunofluorescence
Antibodies against Mecp2 (Millipore), Gfap (Santa Cruz
Bioechnologies or Sigma), ß-tubulin III (Covance), Map2 (Sigma),
Gad67 (Chemicon), RC2 (DSHB), Vimentin (DSHB), and Nestin
(DSHB) were used as described below. Secondary antibodies were
obtained from Invitrogen. Cells cultured in tissue culture plates
were fixed with 4% PFA and washed three times in PBS. Cells
were blocked in 3% serum and 0.1% Triton-X for 60 min.
Primary antibodies were diluted in 3% serum PBS solution and
incubated overnight at 4uC. Cells were washed three times in PBS
and incubated in secondary antibody solution (3% serum in PBS)
for 1 hour at room temperature. After this incubation time,
secondary antibody solution was removed and cells were washed
three times in PBS. Either Volocity software (Improvision) or
manual counting was used for cell quantification.
MTT assay
Cell proliferation was measured using the CellTiter
R 96
AQueous one solution cell proliferation assay (Promega) according
to manufacturer’s instructions with the following modifications:
10610
4cells were plated in 150 ml of media and 30 ml of CellTiter
reagent was added to the culture. The absorbance was read after
4 hours using a precision microplate reader (Molecular Devices) at
490 nm wavelength.
Acknowledgments
We wish to thank Adrian Bird and Egor Prokhortchouk for providing
Mecp2 and Zbtb33 knockout mouse lines, Alan McClure for animal
husbandry, and Maurizio D’Esposito, Ekin Bolukbosi and Nicola Reynolds
for advice and discussions.
Author Contributions
Conceived and designed the experiments: IMC SMP BH. Performed the
experiments: IMC JH DL BH. Analyzed the data: IMC DL SMP BH.
Wrote the paper: IMC BH.
Table 2. RT-PCR Primers used in this study.
Forward Reverse
Mbd1 GAGCACAGAGAATCGCCTTC CACACCCCACAGTCCTCTTT
Mbd2 CTGGCAAGATACCTGGGAAA TTCCGGAGTCTCTGCTTGTT
Mbd3 AGAAGAACCCTGGTGTGTGG TGTACCAGCTCCTCCTGCTT
Mbd4 ACAGGATGGCTCTGAAATGC TCTACTTGTGTCCGTGGGATG
Zbtb33 GGAGCAGGCATGGAGAGTAG GGAATTTTCGGTCTTCCACA
MeCP2 CAGGCAAAGCAGAAACATCA GCAAGGTGGGGTCATCATAC
Zbtb4 GCTGCCTTCTCCGATGTCC CAGTAGGATCTGAGGTGACCA
Zbtb38 CATCTTTTGGAGCCATACGATCT TGACGGTTTCCTGTCTTTTGAC
Nkrt2 ATCAGCTATCGAACAATGAGG TCAAGAGGTTCGTCGTGTAG
Sox2 GCGGAGTGGAAACTTTTGTC TATTTATAATCCGGGTGCTCCTT
FabP7 CCAGCTGGGAGAAGAGTTTG TTTCTTTGCCATCCCACTTC
doi:10.1371/journal.pone.0004315.t002
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